More News of Interest

Vixiar Medical Raises $1.5 Million in Seed Round Financing

Vixiar Medical, Inc., a privately held Maryland company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary diseases, announced today that it has raised seed round financing of over $1.5 million.

Proceeds will be used to complete regulatory submissions and fund final engineering and initial production of the Company’s first product, Indicor™, a non-invasive point of care monitoring technology for estimating cardiac filling pressure. The investment group includes representation from Asia, Europe and the US, with local investors including the Abell Foundation, and Maryland’s TEDCO.

Regarding support,Kevin Thibodeau, Vixiar CEO said, “We are excited to receive the support of this group of local and global investors and move forward to achieve our critical milestones including commercialization of our first technology.”  He added, “Heart failure is a growing global healthcare challenge and we are eager to offer clinicians a non-invasive, cost-effective solution for identifying early signs so they can intervene earlier and avoid costly hospitalizations.”

Latest Posts


Don't Miss